Deans' stroke musings: BCI startup NeuroLutions raises $1.15 million to develop a robotic rehabilitation tool for stroke patients

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, June 15, 2015

BCI startup NeuroLutions raises $1.15 million to develop a robotic rehabilitation tool for stroke patients

This will probably only work if your motor cortex is intact. I'm assuming that they aren't sophisticated enough to pick up signals from the premotor cortex or the frontal lobes if the motor cortex is dead like mine is.
http://neurogadget.com/2015/06/15/bci-startup-neurolutions-raises-1-15-million-to-develop-a-robotic-rehabilitation-tool-for-stroke-patients/11392
NeuroLutions, a BCI startup aiming to restore functions to disabled patients, has successfully raised $1.15 million from a group of investors to continue the clinical study of its first product, IpsiHand, which could help patients recover from stroke.
IpsiHand is a robotic rehabilitation tool for stroke patients, developed in partnership by Neurolutions and IncWashington University. The tool has a robotic glove that you wear on your hand and a neurocap that you wear on your head. The BCI headset picks up the patient’s thoughts and sends them to the robotic glove.
To date, NeuroLutions has raised approximately $2 million from previous investors that include Ascension Ventures, BioGenerator, Prolog Ventures and other private investors. Including this most recent round, BioGenerator has now invested $350,000 in the startup.